Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community partnerships for advanced cancer care.
Scott A. Soefje, PharmD
Advertisement
Articles by Scott A. Soefje, PharmD
Scott Soefje, PharmD, MBA, BCOP, of Mayo Clinic, discusses how payer-provider collaboration and pharmacist-led management can help improve oncology care.
With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.
Advertisement
Latest Updated Articles
- Neulasta Onpro: A Coup de Grâce?
March 13th 2023
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
2
Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon
3
GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH
4
5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care
5